Literature DB >> 21448645

Induced sputum as a method for detection of systemic sclerosis-related interstitial lung disease.

Neslihan Yilmaz1, Yasin Abul, Muge Bicakcigil, Pejman Golabi, Cigdem Celikel, Sait Karakurt, Sule Yavuz.   

Abstract

Inducted sputum (IS) is a non-invasive procedure that can be used for collection of airway secretions. The aim of our study is to evaluate the clinical usefulness of IS for detection of airway inflammation in systemic sclerosis (SSc). Bronchoalveolar lavage and IS were performed to 20 patients with SSc. Eighteen patients who were referred to pulmonary medicine for bronchoalveolar lavage due to other reasons were also recruited for cell counts comparisons. Spirometry, echocardiography and thorax CT (HRCT) imaging were also performed to all patients. Mean macrophage and lymphocyte counts were found to be increased in IS of SSc patients compared with that of control (58.4 ± 14.5% vs. 31.3 ± 16.3%, 30.2 ± 15.4% vs. 15.0 ± 11.5% P < 0.001), whereas mean neutrophil count was lower in the SSc patients (4.1 ± 4.5% vs. 17.2 ± 13.1%, P < 0.05). Significant correlations were noted between BAL and IS findings for macrophage (r = 0.55, P = 0.02) lymphocyte (r = 0.65, P < 0.01) and total cell counts (r = 0.45, P = 0.06). IS is an easy and reliable method for the detection of alveolitis and can be used for early detection of lung involvement in scleroderma.

Entities:  

Mesh:

Year:  2011        PMID: 21448645     DOI: 10.1007/s00296-011-1872-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  22 in total

1.  [Comparison of cellular composition of induced sputum, bronchial washings and bronchoalveolar lavage fluid in sarcoidosis, hypersensitivity pneumonitis and COPD].

Authors:  Robert M Mróz; Elzbieta Chyczewska; Małgorzata Korniluk; Anna Stasiak-Barmuta; Maria Ossolińska
Journal:  Pneumonol Alergol Pol       Date:  2002

Review 2.  Induced sputum in interstitial lung diseases: novel insights in the diagnosis, evaluation and research.

Authors:  Foteini Economidou; Katerina D Samara; Katerina M Antoniou; Nikolaos M Siafakas
Journal:  Respiration       Date:  2008-12-18       Impact factor: 3.580

3.  Correlation of CD4:CD8 ratio and tumour necrosis factor (TNF)alpha levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis.

Authors:  Y P Moodley; T Dorasamy; S Venketasamy; V Naicker; U G Lalloo
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

Review 4.  Induced sputum in interstitial lung diseases.

Authors:  Elizabeth Fireman; Yehuda Lerman
Journal:  Curr Opin Pulm Med       Date:  2006-09       Impact factor: 3.155

Review 5.  Evaluation and management of pulmonary fibrosis in scleroderma.

Authors:  Barbara White
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

Review 6.  Interstitial lung disease in systemic sclerosis.

Authors:  Predrag Ostojic; Marco Matucci Cerinic; Richard Silver; Kristin Highland; Nemanja Damjanov
Journal:  Lung       Date:  2007 Jul-Aug       Impact factor: 2.584

7.  Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects.

Authors:  J V Fahy; H Wong; J Liu; H A Boushey
Journal:  Am J Respir Crit Care Med       Date:  1995-07       Impact factor: 21.405

Review 8.  Evaluation and management of alveolitis and interstitial lung disease in scleroderma.

Authors:  Panagiota I Latsi; Athol U Wells
Journal:  Curr Opin Rheumatol       Date:  2003-11       Impact factor: 5.006

9.  Induced sputum as a tool for early detection of airway inflammation in connective diseases-related lung involvement.

Authors:  Alessandro Vatrella; Marialuisa Bocchino; Francesco Perna; Raffaele Scarpa; Domenico Galati; Sergio Spina; Girolamo Pelaia; Mario Cazzola; Alessandro Sanduzzi
Journal:  Respir Med       Date:  2007-03-19       Impact factor: 3.415

10.  Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.

Authors:  Nicole S L Goh; Srihari Veeraraghavan; Sujal R Desai; Derek Cramer; David M Hansell; Christopher P Denton; Carol M Black; Roland M du Bois; Athol U Wells
Journal:  Arthritis Rheum       Date:  2007-06
View more
  2 in total

1.  Inflammatory profile of induced sputum composition in systemic sclerosis and comparison with healthy volunteers.

Authors:  P Jacquerie; M Henket; B André; C Moermans; D de Seny; F Gester; R Louis; M Malaise; J Guiot
Journal:  Sci Rep       Date:  2021-05-21       Impact factor: 4.379

2.  Serum amyloid A is a marker for pulmonary involvement in systemic sclerosis.

Authors:  Katja Lakota; Mary Carns; Sofia Podlusky; Katjusa Mrak-Poljsak; Monique Hinchcliff; Jungwha Lee; Matija Tomsic; Snezna Sodin-Semrl; John Varga
Journal:  PLoS One       Date:  2015-01-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.